The effects of zinc supplementation on olfactory disorders: a systematic review with meta-analysis
- 1Universidade Estadual de Londrina, Department of Clinical Surgery, Londrina, PR, Brazil
- 2Pontifícia Universidade Católica do Paraná, Department of Medicine, Londrina, PR, Brazil
- 3Universidade de São Paulo, Department of Otorhinolaryngology, São Paulo, SP, Brazil
Abstract
Objectives: This systematic review aimed to evaluate the efficacy of zinc supplementation for treating olfactory disorders, including quantitative and qualitative symptoms, in adults.
Methods: We conducted a comprehensive search of the Cochrane Central Register of Controlled Trials, Pubmed, Embase, and other relevant databases for Randomized Controlled Trials (RCTs) and observational studies evaluating zinc supplementation for olfactory dysfunction. Studies published up to April 2025 were included. Improvement in olfactory function was assessed with validated olfactory tests or subjective questionnaires. Qualitative symptoms (parosmia, phantosmia), adverse effects, patient-reported outcomes, and quality of life measured by questionnaires were evaluated.
Results: A total of 6 studies, including 3 RCTs and 3 observational studies, were included in the review. Sample sizes varied between 25 and 606 participants, with follow-up durations ranging from 1 to 15 months. The meta-analysis showed no significant difference in olfactory function improvement between the zinc-treated group and the control group (OR = 1.78; 95% CI 0.63–5.03; p = 0.28). In addition, the analysis of subjective perception of improvement, also did not demonstrate a statistically significant effect (OR = 0.69; 95% CI 0.25–1.93; p = 0.48). However, an individual study reported improvement in specific subgroups, such as those with posttraumatic anosmia. Adverse events were generally mild and primarily gastrointestinal.
Conclusion: Current evidence does not support a clear benefit of zinc supplementation for olfactory disorders. Further high-quality RCTs are necessary to determine its potential role, particularly in targeted subgroups.
Level of evidence: Level 2a.
Related
- The effects of olfactory stimulation on postural control in adults: A systematic review
- Postmortem Alterations of Metabotropic Glutamate Receptors across Neuropsychiatric Disorders: A Systematic Review
- Is plant-based protein supplementation as effective as whey protein? A systematic review and meta-analysis in untrained adults undergoing resistance training.
- Omega-3 polyunsaturated fatty acid supplementation for the management of exercise-induced bronchoconstriction: a systematic review and meta-analysis
- Effects of creatine supplementation on lean mass, muscle size and muscle performance during immobilisation and rehabilitation: A systematic review.
BibTeX
@article{fornazieri2026effects,
title = {{The effects of zinc supplementation on olfactory disorders: a systematic review with meta-analysis}},
author = {Marco Aurélio Fornazieri and Heloísa Bortholazzi Fornazieri and Nayara Anitelli Artero and Ellen Cristine Duarte Garcia and Fábio de Rezende Pinna and Richard Louis Voegels},
journal = {Brazilian Journal of Otorhinolaryngology},
year = {2026},
month = oct,
doi = {10.1016/j.bjorl.2026.101914},
url = {https://doi.org/10.1016/j.bjorl.2026.101914},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The effects of zinc supplementation on olfactory disorders: a systematic review with meta-analysis
AU - Marco Aurélio Fornazieri
AU - Heloísa Bortholazzi Fornazieri
AU - Nayara Anitelli Artero
AU - Ellen Cristine Duarte Garcia
AU - Fábio de Rezende Pinna
AU - Richard Louis Voegels
PY - 2026
DA - 2026/10/28
JO - Brazilian Journal of Otorhinolaryngology
DO - 10.1016/j.bjorl.2026.101914
UR - https://doi.org/10.1016/j.bjorl.2026.101914
AB - Objectives: This systematic review aimed to evaluate the efficacy of zinc supplementation for treating olfactory disorders, including quantitative and qualitative symptoms, in adults. Methods: We conducted a comprehensive search of the Cochrane Central Register of Controlled Trials, Pubmed, Embase, and other relevant databases for Randomized Controlled Trials (RCTs) and observational studies evaluating zinc supplementation for olfactory dysfunction. Studies published up to April 2025 were included. Improvement in olfactory function was assessed with validated olfactory tests or subjective questionnaires. Qualitative symptoms (parosmia, phantosmia), adverse effects, patient-reported outcomes, and quality of life measured by questionnaires were evaluated. Results: A total of 6 studies, including 3 RCTs and 3 observational studies, were included in the review. Sample sizes varied between 25 and 606 participants, with follow-up durations ranging from 1 to 15 months. The meta-analysis showed no significant difference in olfactory function improvement between the zinc-treated group and the control group (OR = 1.78; 95% CI 0.63–5.03; p = 0.28). In addition, the analysis of subjective perception of improvement, also did not demonstrate a statistically significant effect (OR = 0.69; 95% CI 0.25–1.93; p = 0.48). However, an individual study reported improvement in specific subgroups, such as those with posttraumatic anosmia. Adverse events were generally mild and primarily gastrointestinal. Conclusion: Current evidence does not support a clear benefit of zinc supplementation for olfactory disorders. Further high-quality RCTs are necessary to determine its potential role, particularly in targeted subgroups. Level of evidence: Level 2a.
SN - 1808-8694
SN - 1808-8686
ER -